Ford Catherine, Chibwesha Carla J, Winston Jennifer, Jacobs Choolwe, Lubeya Mwansa Ketty, Musonda Patrick, Stringer Jeffrey S A, Chi Benjamin H
a School of Medicine , University of North Carolina , Chapel Hill , NC , USA.
b School of Public Health , University of Zambia , Lusaka , Zambia.
AIDS Care. 2018 Apr;30(4):426-434. doi: 10.1080/09540121.2017.1381328. Epub 2017 Oct 3.
Women's empowerment is associated with engagement in some areas of healthcare, but its role in prevention of mother-to-child HIV transmission (PMTCT) services has not been previously considered. In this secondary analysis, we investigated the association of women's decision-making and uptake of health services for PMTCT. Using data from population-based household surveys, we included women who reported delivery in the 2-year period prior to the survey and were HIV-infected. We measured a woman's self-reported role in decision-making in her own healthcare, making of large purchases, schooling of children, and healthcare for children. For each domain, respondents were categorized as having an "active" or "no active" role. We investigated associations between decision-making and specific steps along the PMTCT cascade: uptake of maternal antiretroviral drugs, uptake of infant HIV prophylaxis, and infant HIV testing. We calculated unadjusted and adjusted odds ratios via logistic regression. From March to December 2011, 344 HIV-infected mothers were surveyed and 276 completed the relevant survey questions. Of these, 190 (69%) took antiretroviral drugs during pregnancy; 175 (64%) of their HIV-exposed infants received antiretroviral prophylaxis; and 160 (58%) had their infant tested for HIV. There was no association between decision-making and maternal or infant antiretroviral drug use. We observed a significant association between decision-making and infant HIV testing in univariate analyses (OR 1.56-1.85; p < 0.05); however, odds ratios for the decision-making indicators were no longer statistically significant predictors of infant HIV testing in multivariate analyses. In conclusion, women who reported an active role in decision-making trended toward a higher likelihood of uptake of infant testing in the PMTCT cascade. Larger studies are needed to evaluate the impact of empowerment initiatives on the PMTCT service utilization overall and infant testing in particular.
妇女赋权与参与某些医疗保健领域有关,但此前尚未考虑其在预防母婴传播艾滋病毒(PMTCT)服务中的作用。在这项二次分析中,我们调查了妇女在PMTCT健康服务决策和接受方面的关联。利用基于人群的家庭调查数据,我们纳入了在调查前2年内报告分娩且感染艾滋病毒的妇女。我们衡量了女性在自身医疗保健决策、大宗采购决策、子女教育决策和子女医疗保健决策中自我报告的角色。对于每个领域,受访者被分类为具有“积极”或“不积极”的角色。我们调查了决策与PMTCT级联中的具体步骤之间的关联:孕产妇抗逆转录病毒药物的使用、婴儿艾滋病毒预防用药的使用以及婴儿艾滋病毒检测。我们通过逻辑回归计算未调整和调整后的比值比。2011年3月至12月,对344名感染艾滋病毒的母亲进行了调查,276名完成了相关调查问题。其中,190名(69%)在孕期服用了抗逆转录病毒药物;其175名(64%)艾滋病毒暴露婴儿接受了抗逆转录病毒预防用药;160名(58%)对其婴儿进行了艾滋病毒检测。决策与孕产妇或婴儿抗逆转录病毒药物使用之间没有关联。在单变量分析中,我们观察到决策与婴儿艾滋病毒检测之间存在显著关联(比值比1.56 - 1.85;p < 0.05);然而,在多变量分析中,决策指标的比值比不再是婴儿艾滋病毒检测的统计学显著预测因素。总之,报告在决策中发挥积极作用的妇女在PMTCT级联中接受婴儿检测的可能性更高。需要开展更大规模的研究,以评估赋权举措对整体PMTCT服务利用,特别是对婴儿检测的影响。